PT1035835E - Formulacoes injectaveis de accao prolongada contendo oleo de ricino hidrogenado - Google Patents

Formulacoes injectaveis de accao prolongada contendo oleo de ricino hidrogenado

Info

Publication number
PT1035835E
PT1035835E PT98946961T PT98946961T PT1035835E PT 1035835 E PT1035835 E PT 1035835E PT 98946961 T PT98946961 T PT 98946961T PT 98946961 T PT98946961 T PT 98946961T PT 1035835 E PT1035835 E PT 1035835E
Authority
PT
Portugal
Prior art keywords
ricino
injectable formulations
prolonged action
action containing
hydrogenate
Prior art date
Application number
PT98946961T
Other languages
English (en)
Inventor
James B Williams
Rey T Chern
Original Assignee
Merck & Co Inc
Merial Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1035835(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9809792.6A external-priority patent/GB9809792D0/en
Application filed by Merck & Co Inc, Merial Llc filed Critical Merck & Co Inc
Publication of PT1035835E publication Critical patent/PT1035835E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98946961T 1997-12-03 1998-09-14 Formulacoes injectaveis de accao prolongada contendo oleo de ricino hidrogenado PT1035835E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6737497P 1997-12-03 1997-12-03
GBGB9809792.6A GB9809792D0 (en) 1998-05-07 1998-05-07 Long acting injectable formulations containing hydrogenated castor oil

Publications (1)

Publication Number Publication Date
PT1035835E true PT1035835E (pt) 2003-12-31

Family

ID=26313620

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98946961T PT1035835E (pt) 1997-12-03 1998-09-14 Formulacoes injectaveis de accao prolongada contendo oleo de ricino hidrogenado

Country Status (28)

Country Link
EP (1) EP1035835B1 (pt)
JP (1) JP3925900B2 (pt)
KR (1) KR100499438B1 (pt)
CN (1) CN1205921C (pt)
AR (1) AR017779A1 (pt)
AT (1) ATE249206T1 (pt)
AU (1) AU749006B2 (pt)
BG (1) BG65147B1 (pt)
BR (1) BR9815352A (pt)
CA (1) CA2312898C (pt)
CO (1) CO4970836A1 (pt)
DE (1) DE69818093T2 (pt)
DK (1) DK1035835T3 (pt)
EA (1) EA002497B1 (pt)
ES (1) ES2205550T3 (pt)
HK (1) HK1032917A1 (pt)
HR (1) HRP20000366B1 (pt)
HU (1) HU228617B1 (pt)
IL (1) IL136313A (pt)
ME (1) ME00855B (pt)
NO (1) NO329469B1 (pt)
NZ (1) NZ504783A (pt)
PL (1) PL192651B1 (pt)
PT (1) PT1035835E (pt)
RS (1) RS49838B (pt)
SK (1) SK284522B6 (pt)
TW (1) TW550088B (pt)
WO (1) WO1999027906A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538031B1 (en) * 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
CA2472578A1 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
CN1275589C (zh) * 2002-05-31 2006-09-20 王玉万 含抗寄生虫药物的缓释注射剂
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004045581A1 (fr) * 2002-11-18 2004-06-03 Yuwan Wang Injection d'une suspension d'un antiparasite veterinaire
WO2004047803A1 (fr) * 2002-11-27 2004-06-10 Eco Animal Health Ltd Injection de medicament pour animaux renfermant du closantel ou du sodium de closantel
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
AR044437A1 (es) * 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
CN1293921C (zh) * 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2005084688A1 (fr) * 2004-03-04 2005-09-15 Yuwan Wang Poudre injectable contenant un vermifuge
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
DE102006043444A1 (de) * 2006-09-15 2008-03-27 Bayer Cropscience Ag Suspensionskonzentrate auf Ölbasis
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
GB0804619D0 (en) * 2008-03-12 2008-04-16 Norbrook Lab Ltd A topical ectoparasiticide composition
CN102271672B (zh) * 2008-11-19 2015-02-04 梅里亚有限公司 用于治疗寄生物感染的包含单独的或与甲脒组合的1-芳基吡唑的组合物
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA2879477A1 (en) * 2012-07-27 2014-01-30 Novartis Ag New treatment of fish with a nanosuspension of lufenuron or hexaflumuron
MX363173B (es) * 2012-12-12 2019-03-12 Zoetis Services Llc Composiciones inyectables de fenilpirazol.
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN104337761B (zh) * 2013-08-07 2019-03-26 江苏豪森药业集团有限公司 氟维司群药物组合物
RU2646829C1 (ru) * 2013-12-16 2018-03-07 ЗОИТИС СЕРВИСЕЗ ЭлЭлСи Композиции длительного действия на основе кетопрофена
CN103721266A (zh) * 2014-01-06 2014-04-16 王玉万 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂
JP6777734B2 (ja) 2015-06-10 2020-10-28 ピードモント アニマル ヘルス インコーポレイテッド 注射可能な抗生物質製剤及びその使用
WO2020223959A1 (en) * 2019-05-09 2020-11-12 The Procter & Gamble Company Stable anti-mite liquid laundry detergent composition comprising benzyl benzoate
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1060632A (en) * 1962-09-11 1967-03-08 Olin Mathieson Steroid compositions
DE2548413A1 (de) * 1975-10-27 1977-04-28 Schering Ag Depotpraeparate in oeliger ungesaettigter loesung zur intramuskulaeren injektion
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (de) * 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
DE3767560D1 (de) * 1986-03-25 1991-02-28 Sankyo Co Makrolide verbindungen, ihre herstellung und verwendung.
EP0252879B1 (de) * 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) * 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (de) * 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
DE69636706T2 (de) * 1995-09-25 2007-10-11 Ashmont Holdings Ltd., Takapuna Makrocyclische lacton anthelmintika
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl

Also Published As

Publication number Publication date
ATE249206T1 (de) 2003-09-15
BR9815352A (pt) 2000-10-17
JP2001524510A (ja) 2001-12-04
DE69818093D1 (de) 2003-10-16
EP1035835B1 (en) 2003-09-10
HRP20000366A2 (en) 2001-06-30
EP1035835A1 (en) 2000-09-20
CA2312898C (en) 2004-05-11
AU9385898A (en) 1999-06-16
EA200000604A1 (ru) 2000-12-25
PL341542A1 (en) 2001-04-23
KR100499438B1 (ko) 2005-07-07
ES2205550T3 (es) 2004-05-01
NO20002830D0 (no) 2000-06-02
ME00855B (me) 2008-08-07
RS49838B (sr) 2008-08-07
DE69818093T2 (de) 2004-06-09
IL136313A (en) 2005-08-31
PL192651B1 (pl) 2006-11-30
NZ504783A (en) 2002-12-20
AU749006B2 (en) 2002-06-13
BG104560A (en) 2001-04-30
BG65147B1 (bg) 2007-04-30
HRP20000366B1 (en) 2009-08-31
NO20002830L (no) 2000-08-03
HK1032917A1 (en) 2001-08-10
EA002497B1 (ru) 2002-06-27
CN1205921C (zh) 2005-06-15
KR20010032760A (ko) 2001-04-25
SK8292000A3 (en) 2000-11-07
TW550088B (en) 2003-09-01
WO1999027906A1 (en) 1999-06-10
AR017779A1 (es) 2001-10-24
HU228617B1 (en) 2013-04-29
HUP0100606A3 (en) 2002-11-28
CN1283990A (zh) 2001-02-14
IL136313A0 (en) 2001-05-20
YU34500A (sh) 2002-11-15
JP3925900B2 (ja) 2007-06-06
CO4970836A1 (es) 2000-11-07
HUP0100606A2 (hu) 2001-06-28
SK284522B6 (sk) 2005-05-05
CA2312898A1 (en) 1999-06-10
NO329469B1 (no) 2010-10-25
DK1035835T3 (da) 2003-12-08

Similar Documents

Publication Publication Date Title
PT1035835E (pt) Formulacoes injectaveis de accao prolongada contendo oleo de ricino hidrogenado
NO995802D0 (no) Anvendelse av oljemasser
PT996430E (pt) Composicoes de analogos nucleotidicos
DE69810522D1 (de) Schmierölzusammensetzung
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
BR9405665A (pt) Oleo comestível de espargimento
BR9509200A (pt) Composição de matéria
DE69623904D1 (de) Stabile essbare Ölzusammensetzung
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE69826138D1 (de) Parfümzusammensetzung
PT868183E (pt) Formulacoes injectaveis de quinolona
DE69818270D1 (de) Schmierölzusammensetzung
DE69801318D1 (de) Verbesserte ölzusammensetzungen
DE69806812D1 (de) Olivenöl enthaltende nahrungsmittelzusammensetzung
BR9602897A (pt) Composição de barra de sab o
BR9300577A (pt) Oleo lubrificante e uso,como um oleo lubrificante,de uma composicao
ID22379A (id) Hidrogenasi imina enamina
IL133486A0 (en) Compositions comprising ratite oil or active fractions thereof and methods of using these compositions as insect repellents
DE69821101D1 (de) Ester und verbesserte ölzusammensetzungen
FI991343A (fi) Dihydropolyprenolien öljykoostumus
EP0761808A3 (de) Verwendung substituierter Lactone als Riechstoffe
DE69825885D1 (de) Verbesserte ölzusammensetzung
KR970024002U (ko) 오일 리저버의 오일실
ZA9810975B (en) Long acting injectable formulations containing hydrogenated castor oil
SI1035835T1 (en) Long acting injectable formulations containing hydrogenated castor oil